2025 ASH ISTH NBDF WFH monitoring report Confirms Strength of 2021 VWD Diagnosis and Management Guidelines
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of ISTH, shared on X:
”2025 ASH ISTH NBDF WFH monitoring report on the 2021 clinical guidelines on the diagnosis and management of von Willebrand disease. None of the reviewed studies would change the direction or strength of the existing guideline recommendations.”
Read the full article here.
A comprehensive review of recent literature assessed whether updates are needed for the ASH ISTH NHF WFH 2021 guidelines on the diagnosis and management of von Willebrand disease (VWD).
Of 432 studies screened for diagnosis and 288 for management, a subset underwent full text review, but none provided evidence strong enough to alter the current recommendations in direction or strength.
As VWD remains the most common inherited bleeding disorder, continued monitoring of emerging data is planned to ensure the guidelines remain current and evidence-based.
Find latest scientific updates on von Willebrand disease featured in Hemostasis Today.
-
Oct 5, 2026, 13:09Rick Matthews: Balancing Established VTE Partnerships with Innovative Interventional Technologies
-
Oct 5, 2026, 13:01Nawsherwan Mohammad: Recognizing TTP Before the ADAMTS13 Result Arrives
-
Oct 5, 2026, 12:51Bruno Pougault: The Hidden Challenges Behind Anti Xa Testing
-
Oct 5, 2026, 12:41Syed Huzaifa Khan: Rethinking CTRP12 as a Biomarker for In Stent Restenosis
-
Oct 5, 2026, 12:29Mirvat Alasnag: Creating a Space for Women in Cardiovascular Medicine
-
Oct 5, 2026, 11:59Khaoula Mazouzi: The Potential of Haemoglobin Vesicles as an Oxygen Carrier
-
Oct 5, 2026, 11:56Muhammet Özbilen: What Does New Evidence Tell Us About IV Iron in Pregnancy?
-
Oct 5, 2026, 11:42Fonkou Steve: A Moment to Celebrate the Journey Ahead
-
Oct 5, 2026, 11:33Abeeha Faisal: Beyond the Textbooks – A Day With Children Living With Thalassemia